Acridine orange could be an innovative anticancer agent under photon energy

In Vivo

Volumn 21, Issue 2, 2007, Pages 205-214

  Kusuzaki, Katsuyuki ^a   Murata, Hiroaki ^b   Matsubara, Takao ^a   Satonaka, Haruhiko ^a   Wakabayashi, Toru ^a   Matsumine, Akihiko ^a   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Acridine orange; Musculoskeletal sarcoma; Photodynamic therapy; Photon energy; Radiation; Review

Indexed keywords

ACRIDINE ORANGE; LYSOSOME ENZYME; ANTINEOPLASTIC AGENT;

ADULT; ANTINEOPLASTIC ACTIVITY; BONE RADIOGRAPHY; CANCER SIZE; CASE REPORT; CLINICAL TRIAL; DISABILITY; DRUG EFFICACY; FLUOROSCOPY; HAND FUNCTION; HUMAN; LIMB MOVEMENT; MALE; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PHOTODYNAMIC THERAPY; PHOTON THERAPY; REVIEW; ANIMAL; ARTICLE; BONE TUMOR; CELL SURVIVAL; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HISTIOCYTOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MIDDLE AGED; MOUSE; MUSCULOSKELETAL DISEASE; PATHOLOGY; PHOTON; TREATMENT OUTCOME;

ACRIDINE ORANGE; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL SURVIVAL; HISTIOCYTOMA; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MALE; MICE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; NEOPLASMS, EXPERIMENTAL; OSTEOSARCOMA; PHOTONS; TREATMENT OUTCOME;

EID: 34047218624     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kusuzaki K, Minami G, Takeshita H, Murata H, Hashiguchi S, Nozaki I, Ashihara T and Hirasawa Y: Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 91: 439-445, 2000.
2. Kusuzaki K, Aomori, K, Suginoshita, Minami G, Takeshita Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas by photodynamic reaction with acridine orange. Oncology-Bazel 59: 174-180, 2000.
3. Kusuzaki K, Suginoshita T, Minami G, Aomori K, Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Fluorovisualization effect of acridine orange on mouse osteosarcoma. Anticancer Res 20: 3019-3024, 2000.
4. Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T and Hirasawa Y: Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology-Bazel 62: 85-93, 2002.
5. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical outcome of a new photodynamic therapy with acridine orange for synovial sarcomas. Photochem Photobiol 81: 705-709, 2005.
6. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Res 25: 1225-1236, 2005.
7. Lewis RM and Goland PP: In vivo staining and retardation of tumors in mice by acridine compounds. Am J Med Sci 215: 282-289, 1948.
8. Korgaonkar K and Sukhatankara J: Anti-tumor activity of the fluorescent dye, acridine orange, on Yoshida sarcoma (ascites). Br J Cancer 17: 471-473, 1963.
9. Zdolsek JM, Olsson GM and Brunk UT: Photooxidative damage to lysosomes of cultured macrophages by acridine orange. Photochem Photobiol 51: 67-76, 1990.
10. Sastry KS and Gordon MP: The photodynamic inactivation of tobacco mosaic virus and its ribonucleic acid by acridine orange. Biochim Biophys Acta 129: 32-41, 1966.
11. Zampieri A and Greenberg J: Mutagenesis by acridine orange and proflavin in Escherichia coli strain S. Mutat Res 2: 552-556, 1965.
12. McCann J, Choi E, Yamasaki E and Ames BN: Detection of carcinogenesis as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA 72: 5135-5139, 1975.
13. Giorgio A, Rambaldi M, Maccario P, Ambrosone L and Moles DA: Detection of microorganisms in clinical specimens using slides prestained with acridine orange (AOS). Microbiologica 12: 97-100, 1989.
14. Rickman L, Long G, Oberst R, Cabanban A, Sangalang R, Smith J, Chulay J and Hoffman S: Rapid diagnosis of malaria by acridine orange staining of centrifuged parasites. Lancet 14: 68-71, 1989.
15. Kapuscinski J, Darzynkiewicz Z and Melamed MR: Interactions of acridine orange with nucleic acids. Properties of complexes of acridine orange with single stranded ribonucleic acid. Biochem Pharmacol 32: 3679-3694, 1983.
16. Amagasa J: Mechanisms of photodynamic inactivation of acridine orange-sensitized transfer RNA: participation of singlet oxygen and base damage leading to inactivation. J Radiat Res (Tokyo) 27: 339-351, 1986.
17. Zelenin AV: Fluorescence microscopy of lysosomes and related structures in living cells. Nature 212: 425-426, 1966.
18. Kusuzaki K, Murata H, Takeshita H, Hashiguchi S, Nozaki T, Emoto K, Ashihara T and Hirasawa Y: Intracellular binding sites of acridine orange in living osteosarcoma cells. Anticancer Res 20: 971-976, 2000.
19. International Agency for Research on Cancer. Acridine Orange. In: IARC Monographs Program on the Evaluation of Carcinogenic Risks to Human. IARC Press, Lyon 16: 145, 1978.
20. Matsubara T, Kusuzaki K, Matsumine A, Shintani K, Satonaka H and Uchida A: Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient. Anticancer Res 26: 187-194, 2006.
21. Vrouenreats MB, Visser GWM, Snow GB and van Dongen GAMS: Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 23: 505-522, 2003.
22. Zagar GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS and Evans HL: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer 97: 2530-2543, 2003.
23. Duffaud F, Digue L, Mercier C, Dales JP, Baciuchka-Palmaro M, Volot F, Thomas P and Favre R: Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy. Eur J Cancer 39: 2050-2057, 2003.
24. Krolenko SA, Adamyan SY, Belyaeva TN and Mozhenok TP: Acridine orange accumulation in acidic organelles of normal and vacuolated frog skeletal muscles fibers. Cell Biol Int 20: 1-7, 2006
25. Millot C, Millot JM, Morjani H, Desplaces A and Manfait M: Characterization of acidic vesicles in multidrug-resistant and sensitive cancer cells by acridine orange staining and confocal microspectrofluorometry. J Histochem Cytochem 45: 1255-1264, 1997.
26. Hiruma H, Katakura T, Takenami T, Igawa S, Kanoh M, Fujimura T and Kawakami T: Vesicle disruption, plasma membrane bleb formation, and acute cell death by illumination with blue light in acridine orange-loaded malignant melanoma cells. J Photochem Photobiol B: Biology 86: 1-8, 2007.
27. + transport in the interstitial fluid. In: The Tumour Microenvironment: Causes and Consequences of Hypoxia and Acidity. Wiley, Chichester (Novartis Foundation Symposium 240), pp. 46-67, 2001.
28. Ueda H, Murata H, Takeshita H, Minami G, Hashiguchi S and Kubo T: Unifiltered xenon light is useful for photodynamic thrapy with acridine orange. Anticancer Res 25: 3979-3984, 2005.
29. Pogue BW, O'Hara JA, Demindenko E, Wilmot CM, Goodwin IA, Chen B, Swartz HM and Hasan T: Photodyamic therapy with vertephorin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res 63: 1025-1033, 2003.
30. Moussavi-Harami F, Mollano A, Martin JA, Ayoob A, Domann FE, Gitelis S and Buckwalter JA: Intrinsic radiation resistance in human chondrosarcoma. BBRC 346: 379-385, 2006.